Century Therapeutics, Inc. — Director's Dealing 2024

Jun 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-06-20

Reporting Person: Quimi Daphne (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-20	Stock Option (right to buy)	$2.69	A	44000	Acquired	2034-06-20	Common Stock (44000)	Direct

Footnotes

F1: The option vests on the earlier of (a) June 20, 2025, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date.